KORU Medical Systems, Inc. (NASDAQ:KRMD)

Monday, January 13, 2025 | Web News
KORU Medical Systems (NASDAQ:KRMD) ($3.96; $181.9M market cap), announced preliminary Q4 2024 results: Preliminary,...
Thursday, March 14, 2024 | Web News
KORU Medical Systems (NASDAQ:KRMD) ($2.12; $96.8M market cap), announced Q4 2023 results: Q4 sales of...
Thursday, November 9, 2023 | Web News
KORU Medical Systems (NASDAQ:KRMD) ($2.19; $99.9M market cap), a home infusion therapy medical device company, announced Q3 2023...
See All Research...
Tuesday, October 7, 2014, 9:25 AM
Repro-Med Systems' Focus On The Home-Care Market Could Lead To Substantial Payoff Or Buyout
See All Articles and Reports...
Sunday, February 2, 2025, 3:23 PM
Why We’re Confident in Adding This Medical Device Stock to Run to $1 Model Portfolio After Our Fireside Chat [GeoWire Weekly No. 172]
Monday, January 20, 2025, 4:28 PM
New Reasons For Tracking on Company With Transformative Contract And Possible InfoArb Opportunity [GeoWire Weekly No. 170]
Sunday, October 20, 2024, 1:25 PM
Setting The Record Straight on Why We Do What We Do!! [GeoWire Weekly No. 158]
See All GeoWire Weekly...
KORU Medical Systems develops, manufactures and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60(R) and FreedomEdge(R) Syringe Infusion Drivers, Precision Flow Rate Tubing(TM) and HIgH-Flo Subcutaneous Safety Needle Sets(TM) . These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.

Web site: http://www.repro-med.com

Last updated November 1, 2019


Market Data powered by QuoteMedia. Terms of Use